Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000828

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2021 · Jun 30, 2021 −$120
Total Liabilities Q3 2021 · Jun 30, 2021 $362.16K
Total Liabilities Q3 2021 · Sep 30, 2020 $250.5K
Total Assets Q3 2021 · Jun 30, 2021 $42.79K
Total Assets Q3 2021 · Sep 30, 2020 $408
Net Income Q3 2021 · Jun 30, 2021 −$69.27K
Net Income Q3 2021 · Jun 30, 2020 −$3.56K
Net Income Q3 2021 · Mar 31, 2020 −$3.53K
Net Income Q3 2021 · Dec 31, 2019 −$3.52K
Operating Income Q3 2021 · Jun 30, 2021 −$65.06K
Operating Income Q3 2021 · Jun 30, 2020 −$1.2K
Stockholders Equity Q3 2021 · Sep 30, 2020 −$250.1K
Stockholders Equity Q3 2021 · Jun 30, 2020 −$245.69K
Stockholders Equity Q3 2021 · Mar 31, 2020 −$242.13K
Stockholders Equity Q3 2021 · Dec 31, 2019 −$238.61K